Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
about
Neuroprotection in GlaucomaPharmacodynamics of memantine: an update.Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line.Assessment of neuroprotection in the retina with DARC.Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells.Hyperbaric pressure and increased susceptibility to glutamate toxicity in retinal ganglion cells in vitroCurrent concepts in the pathophysiology of glaucomaSerial multifocal electroretinograms during long-term elevation and reduction of intraocular pressure in non-human primatesNew directions in the treatment of normal tension glaucoma.Structure/function studies and the effects of memantine in monkeys with experimental glaucoma.Neuroprotective effects of flavonoids on hypoxia-, glutamate-, and oxidative stress-induced retinal ganglion cell death.Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes.The non-human primate experimental glaucoma model.Closed gateways--can neuroprotectants shield the retina in glaucoma?Neuroprotection in glaucoma: drug-based approaches.Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina.A case for neuroprotection in ophthalmology: developments in translational research.Control of intracellular calcium signaling as a neuroprotective strategyMechanisms of retinal ganglion cell injury and defense in glaucoma.Autocrine and paracrine interactions and neuroprotection in glaucoma.Microcystic changes in the retinal internal nuclear layer associated with optic atrophy: a prospective studyNeuroprotective therapies for glaucoma.Present and New Treatment Strategies in the Management of Glaucoma.Protecting retinal ganglion cells.Efferent influences on the bioelectrical activity of the retina in primates.Using the electroretinogram to understand how intraocular pressure elevation affects the rat retinaAssessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.Translating Drugs From Animals to Humans: Do We Need to Prove Efficacy?Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study.Dendrite plasticity in the lateral geniculate nucleus in primate glaucoma.Electroretinogram and visual-evoked potential assessment of retinal and central visual function in a rat ocular hypertension model of glaucoma.Annexins in Glaucoma.Translational Pharmacology in Glaucoma Neuroprotection.Therapeutic potential of valproic acid in advanced glaucoma: A pilot study
P2860
Q26740388-1FDE7801-B9FA-4295-AFCF-4B1F047D673FQ30490604-6FB3B0B2-3089-4F0F-B542-ECFAE4EABF1FQ33301067-C411463A-4F55-4EA1-BD6A-03AD6698AE86Q33377667-57C06D6F-60A5-4E1B-993B-2570D5DA3AADQ33443011-F75F9781-4EBF-4503-99AF-33F85E52731EQ33461601-908BF06C-7228-42AB-B411-EF92D7D43E59Q33477806-1834824A-084D-451A-BAE2-BFF8B729B652Q33565815-CABFA2CC-90DD-4A6C-98A8-2B83468B805BQ33785942-90F88EB8-A2F8-4C24-8B95-48E30EDE5F93Q34199498-D5B85EBB-427E-4C00-8552-65054D88D026Q35097109-67EECE23-99E5-440F-92A1-AAABA60B4789Q35217579-927FB775-1AAE-446D-A939-AABD8F4361F4Q36236878-A970D4D4-12BF-47E9-97E6-F5E7DD21DBD7Q36648977-A7D34B9C-0A73-4878-AAF3-CFE9F7285BDAQ37180770-5BD7F302-8127-4376-BAEF-32D0510EBBC6Q37184094-5897BFAB-61B2-4165-B03E-E258B8BB01AEQ37680649-570676F4-3878-48A5-A117-6B23ECBBFF58Q37718540-60C17876-1463-440D-8ED5-5BE5E742627DQ37731595-98A9F13C-310A-490A-91F9-6C2FF90502A2Q38077464-119322F3-7AD6-4225-9774-6343F4E07437Q38257797-70A1D1AB-4867-40FA-B0ED-FE814260C295Q38384978-01DAA6CD-B8AF-4F06-B67E-269CE064131AQ38526185-374E0A68-71D6-45EA-BDBB-93C7C0D2BB33Q38770799-A00ECE31-23C5-4BA8-97B0-0767A019F20DQ39061898-DE44EB72-53F4-4593-B3AA-839B55D13ACDQ41763046-19422737-1B1D-43BF-A5FD-7008C4B64C47Q42096215-0F11FDEE-4914-4744-8889-D6F2E9A8472FQ42119265-951CAFFE-1504-48E7-9804-B90A826D72CDQ42511040-5CA0EE69-05A7-4A06-B0BF-5498D1B78226Q42779249-D38D7D43-F1B4-4E0A-AC3D-5202B50F262CQ45326009-7F0DBB9B-D37C-48C1-91C2-ADB646DEC7F4Q52577506-04C88571-5C89-4092-AAE2-75F9154815ADQ53842256-8E438D9F-6668-4447-9229-EFE1F903CAC3Q58806252-AA23D490-3278-4EA1-B2BC-91815B9EC019
P2860
Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Efficacy and safety of memanti ...... onkey, I: Functional measures.
@ast
Efficacy and safety of memanti ...... onkey, I: Functional measures.
@en
type
label
Efficacy and safety of memanti ...... onkey, I: Functional measures.
@ast
Efficacy and safety of memanti ...... onkey, I: Functional measures.
@en
prefLabel
Efficacy and safety of memanti ...... onkey, I: Functional measures.
@ast
Efficacy and safety of memanti ...... onkey, I: Functional measures.
@en
P2093
P356
P1476
Efficacy and safety of memanti ...... onkey, I: Functional measures.
@en
P2093
Elizabeth WoldeMussie
Guadalupe Ruiz
Larry Wheeler
Ronald K Lai
Teresa Chun
William A Hare
P304
P356
10.1167/IOVS.03-0566
P407
P577
2004-08-01T00:00:00Z